
The GPT-4 Episode: Microsoft’s Peter Lee on the Future of Language Models in Medicine
NEJM AI Grand Rounds
The Parallels Between OpenAI and Biotech
OpenAI's focus is very similar to the kind of focus that a small bio pharma startup might have. They might really be just focused on the binding affinity of a single type of infectious agent. And there are parts of the company and then collaborators we have across academia that are really benefiting from all that. Yeah, and it may be the most important thing of our current era in science technology.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.